These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19065890)

  • 1. [Combined therapy of shehuang paste and colonic dialysis with Chinese medicines for treatment of refractory cirrhotic ascites complicated with azotemia].
    Tong GD; Zhou DQ; He JS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):788-92. PubMed ID: 19065890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia.
    Tong GD; Zhou DQ; He JS; Zhang L; Chen ZF; Xiao CL; Peng LS
    World J Gastroenterol; 2006 Dec; 12(48):7798-804. PubMed ID: 17203523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Shehuang Paste on hemodynamics, endotoxin, nitric oxide and endothelin-1 in patients with refractory cirrhotic ascites.
    Tong GD; Zhou DQ; He JS; Li SL; Peng LS
    Chin J Integr Med; 2006 Dec; 12(4):255-61. PubMed ID: 17361520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Chinese herbal cataplasm Xiaozhang Tie on cirrhotic ascites.
    Xing F; Tan Y; Yan GJ; Zhang JJ; Shi ZH; Tan SZ; Feng NP; Liu CH
    J Ethnopharmacol; 2012 Jan; 139(2):343-9. PubMed ID: 22107835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites].
    Xing F; Li S; Zhang JJ; Sun CY; Huang JR; Gao ZL; Zhu TT; Zhao Q; Zhang H; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):982-988. PubMed ID: 31941260
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial.
    Yang X; Ru S; Luo L; Lv X; Bai W; Zhang F; Jiang F
    Trials; 2019 Feb; 20(1):127. PubMed ID: 30760320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Chinese herbal enema therapy combined basic treatment on BUN, SCr, UA, and IS in chronic renal failure patients].
    Zou C; Wu YC; Lin QZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1192-5. PubMed ID: 23185756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and experimental study of xiaoshui decoction in the treatment of primary liver cancer caused ascites].
    Wu D; Bao WG; Ding YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1066-9. PubMed ID: 16398423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of syndrome dependent umbilical sticking with shizhang cataplasm and xuzhang cataplasm in treating Cirrhosis caused ascites].
    Liu CH; Zhang YL; Feng NP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):411-4. PubMed ID: 16883906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
    Salerno F; Badalamenti S; Lorenzano E; Moser P; Incerti P
    Hepatology; 1991 Apr; 13(4):707-13. PubMed ID: 1826281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of Qi-yin deficiency syndrome type].
    Chen XM; Chen YP; Chen J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):101-5. PubMed ID: 17342992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
    J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multi-centered randomized double-blinded controlled clinical study on efficacy of gulling pa'an capsule in treating Parkinson's disease].
    Zhao GH; Meng QG; Yu XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):590-4. PubMed ID: 19852288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of umbilical sticking therapy with qitou xiaogu plaster in treating liver cirrhosis patients with portal hypertension].
    Shi WQ; Ru QJ; Cai GY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jul; 28(7):642-5. PubMed ID: 18822918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-volume paracentesis versus dialytic ultrafiltration in the treatment of cirrhotic ascites.
    Lai KN; Li P; Law E; Swaminathan R; Nicholls MG
    Q J Med; 1991 Jan; 78(285):33-41. PubMed ID: 1670062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by qizhi jiangtang capsule: a multicenter randomized control clinical study].
    Guo ZA; Yu CJ; Liu G; Meng FC; Li Y; Peng SL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1047-52. PubMed ID: 25335326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.